+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

NovoCure Ltd (NVCR) - Financial and Strategic SWOT Analysis Review

  • ID: 4278898
  • SWOT Analysis
  • April 2021
  • 54 pages
  • GlobalData

FEATURED COMPANIES

  • Advanz Pharma Corp Ltd
  • Flowonix Medical Inc
  • Hologic Inc
  • MagForce AG
  • MDxHealth SA
  • Monteris Medical Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

NovoCure Ltd (NVCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

NovoCure Ltd (NovoCure) develops and commercializes novel delivery systems for the treatment of cancers of brain and abdomen. Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division solid tumor cancer cells. The company markets TTF-based delivery systems: Optune Lua for the treatment of malignant pleural mesothelioma; and Optune for the treatment of glioblastoma. Both of its marketed products are indicated in combination with standard chemotherapies. NovoCure is also advancing product development and clinical programs intended to improve the survival of patients with pancreatic cancer, brain metastases, ovarian cancer, liver cancer, gastric cancer, and non-small cell lung cancer. It has subsidiaries in Europe, the Middle East, Asia, and North America. NovoCure is headquartered in Saint Helier, Jersey, the UK.

NovoCure Ltd Key Recent Developments

Apr 01,2021: Novocure to Report First Quarter 2021 Financial Results
Feb 25,2021: Novocure reports fourth quarter and full year 2020 financial results and provides company update
Feb 08,2021: Novocure announces addition to its board of directors
Jan 11,2021: Novocure announces fourth quarter and full year 2020 preliminary net revenues and provides company update
Nov 19,2020: Novocure announces 43 presentations on tumor treating fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Advanz Pharma Corp Ltd
  • Flowonix Medical Inc
  • Hologic Inc
  • MagForce AG
  • MDxHealth SA
  • Monteris Medical Inc
Section 1 - About the Company
  • NovoCure Ltd - Key Facts
  • NovoCure Ltd - Key Employees
  • NovoCure Ltd - Key Employee Biographies
  • NovoCure Ltd - Major Products and Services
  • NovoCure Ltd - History
  • NovoCure Ltd - Company Statement
  • NovoCure Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • NovoCure Ltd - Business Description
  • Geographical Segment: EMEA
  • Performance
  • Geographical Segment: Greater China
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • NovoCure Ltd - Corporate Strategy
  • NovoCure Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • NovoCure Ltd - Strengths
  • NovoCure Ltd - Weaknesses
  • NovoCure Ltd - Opportunities
  • NovoCure Ltd - Threats
  • NovoCure Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • NovoCure Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
  • NovoCure Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
  • NovoCure Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 01, 2021: Novocure to Report First Quarter 2021 Financial Results
  • Feb 25, 2021: Novocure reports fourth quarter and full year 2020 financial results and provides company update
  • Feb 08, 2021: Novocure announces addition to its board of directors
  • Jan 11, 2021: Novocure announces fourth quarter and full year 2020 preliminary net revenues and provides company update
  • Nov 19, 2020: Novocure announces 43 presentations on tumor treating fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting
  • Nov 10, 2020: Novocure announces agenda for Virtual Research and Development Day
  • Nov 02, 2020: Novocure announces proposed private placement of $500 million of convertible senior notes
  • Oct 29, 2020: Novocure reports third quarter 2020 financial results and provides company update
  • Oct 29, 2020: Novocure announces strategic alliance with NYU Grossman School of Medicine for preclinical and clinical Research
  • Aug 13, 2020: Novocure announces expansion of its executive leadership team
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • NovoCure Ltd, Key Facts
  • NovoCure Ltd, Key Employees
  • NovoCure Ltd, Key Employee Biographies
  • NovoCure Ltd, Major Products and Services
  • NovoCure Ltd, History
  • NovoCure Ltd, Subsidiaries
  • NovoCure Ltd, Key Competitors
  • NovoCure Ltd, Ratios based on current share price
  • NovoCure Ltd, Annual
  • NovoCure Ltd, Interim Ratios
  • NovoCure Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
  • NovoCure Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
  • NovoCure Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • NovoCure Ltd, Performance Chart (2016 - 2020)
  • NovoCure Ltd, Ratio Charts
  • NovoCure Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
  • NovoCure Ltd, Medical Equipment, Deals by Type, 2015 to YTD 2021
Note: Product cover images may vary from those shown

Loading
LOADING...

  • SonALASense Inc
  • Monteris Medical Inc
  • MDxHealth SA
  • MagForce AG
  • Hologic Inc
  • Flowonix Medical Inc
  • Advanz Pharma Corp Ltd
Note: Product cover images may vary from those shown
Adroll
adroll